cells
cell
zikv
sanofi
gbs
retinal
journal
zika virus
develop
development
developing
developed
vaccine
vaccines
increased
increasing
antiviral
layer
layers
cases
case
syndrome associated
including
included
deficiency
association
associations
infections
infection
infected
c
times
time
effective antivirals
brazil
result
results
resulting
percent
mmpr effectively
mod
change
changes
company
sep
population
populations
et
controls
j
plos
neuronal
fund
federal funding
source
agents
reported
reports
reporting
report
severe neurologic
czs
neurological
health began
statement
statements
headache
america
americas
teaching
prior
condition
azathioprine
models
model
press
financial
human
humans
study
maldevelopment
thu
said
profile
profiles
age
commercially
symptoms
strongly
provide strong
provided
provides
nucleoside
ganglion
ophthalmology
ophthalmologic
laboratory
laboratories
working
work
photoreceptor
understanding
pathophysiologic
pathophysiology
segmented
segmentation algorithms
army
reed
flavivirus
al
atrophy
gcl
eye
eyes
edited
shows
showing
showed
vivo
normally
normal
abnormalities
examined
examining
priced
pricing
prices
